F-1/A: Lytus Technologies Amends F-1 for Nasdaq Uplisting & Public Offering

Lytus Technologies Holdings PTV. Ltd. filed an amended F-1 registration statement for a public offering of 1.13 million common shares, contingent on Nasdaq Capital Market listing, despite a recent decline in net income.

Summary

• Lytus Technologies Holdings PTV. Ltd. is offering 1,132,076 common shares in a firm commitment underwritten public offering at an assumed price of $13.25 per share, with an expected range of $13.00 to $15.00.
• The offering is contingent upon the approval of the company's common shares for listing on the Nasdaq Capital Market under the symbol 'LYT'.
• Net proceeds from the offering, estimated at approximately $14 million, will be used to repay a $1.6 million promissory note to Yorkville and allocate $12.4 million for working capital and general corporate purposes, including potential strategic transactions.
• The company operates primarily in India, offering linear content streaming/telecasting services, and developing healthtech and fintech products.
• For the six months ended September 30, 2025, total revenue increased by 20% to $14,425,228, compared to $12,052,318 for the same period in 2024.
• However, net income after tax decreased by 48% to $340,031 for the six months ended September 30, 2025, from $648,972 in the prior year period.
• Cost of revenue increased by 29% to $11,385,615 for the six months ended September 30, 2025, primarily due to a decrease in subscriber levels while fixed costs remained constant.
• The company's user base is estimated at over four million active users across India, based on 1 million paid home subscribers multiplied by an industry average of 4.4 users per household.
• A 1-for-2,500 reverse stock split became effective on September 26, 2025, to meet Nasdaq listing requirements.
• The Lytus Trust, controlled by the CEO, will own slightly more than 50% of the voting power post-offering, maintaining controlled company status under Nasdaq rules.
• The company has identified material weaknesses in its internal control over financial reporting as of September 30, 2025, and March 31, 2025.
• On October 1, 2025, the company acquired Sree Devi Digital Systems Private Limited and Sree Devi Communication Private Limited, with a 51% stake held by its subsidiary Lytus Sri Sai Networks Private Limited.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with mixed sentiment. While the revenue growth and strategic expansion plans are positive, the significant decline in net income, identified material weaknesses in internal controls, and the prior Nasdaq delisting raise substantial concerns about operational efficiency and financial health. The capital raise is crucial but comes with considerable risks.

Positives

• Total revenue increased by 20% to $14,425,228 for the six months ended September 30, 2025, demonstrating business growth.
• The company is actively pursuing a Nasdaq Capital Market listing, which could enhance liquidity and investor visibility.
• Strategic expansion into healthtech and fintech, leveraging existing cable network infrastructure and a large subscriber base in India, presents significant growth opportunities.
• The acquisition of Sree Devi Digital Systems Private Limited and Sree Devi Communication Private Limited on October 1, 2025, expands the cable and broadband business.
• Management believes the offering proceeds will cover cash needs for the next 12 months, providing financial stability for immediate operations and growth initiatives.

Negatives

• Net income after tax decreased significantly by 48% to $340,031 for the six months ended September 30, 2025, despite revenue growth.
• Cost of revenue increased by 29% for the six months ended September 30, 2025, outpacing revenue growth and impacting profitability.
• The company has identified material weaknesses in its internal control over financial reporting and ineffective disclosure controls and procedures as of September 30, 2025, and March 31, 2025.
• The company's common shares were delisted from Nasdaq on March 31, 2025, and now trade on the OTCID, indicating past compliance issues and reduced market access.
• The estimated four million user base is based on assumptions (1 million paid subscribers x 4.4 users/household) which may not be accurate, potentially overstating active users.
• A pending lawsuit against CEO Dharmesh Pandya for breach of contract and fiduciary duty, claiming $854,000 in damages, poses a legal and reputational risk.

Risks

• Uncertainty regarding the development or sustainability of an active public trading market for common shares.
• The current quotation on OTCID may negatively impact stock price and liquidity, and there is no assurance of Nasdaq listing approval or maintenance.
• U.S. broker-dealers may be discouraged from trading common shares if they are considered 'penny stock', limiting market liquidity.
• Substantial future sales of common shares or the perception of such sales could depress the stock price and cause dilution.
• Management has broad discretion in using offering proceeds, which may not yield a favorable return on investment.
• As a foreign private issuer, disclosure obligations differ from U.S. domestic issuers, potentially making it harder for investors to evaluate performance.
• The company's controlled company status allows reliance on exemptions from certain Nasdaq corporate governance requirements, potentially offering less protection to shareholders.
• The CEO and principal shareholder, Lytus Trust, holds significant voting control, which could discourage or prevent a change in control.
• Dilution may result from the conversion of outstanding notes at a discount to market price.
• Shareholders under BVI law may have fewer protections compared to U.S. law.
• The company may become a Passive Foreign Investment Company (PFIC), leading to adverse U.S. tax consequences for U.S. investors.
• Limited operating history and rapid growth make evaluating current business and future prospects difficult, increasing investment risk.
• Revenues and expenses are difficult to predict due to market volatility, increasing the likelihood of results falling below expectations.
• Risks related to storage of confidential customer information and cybersecurity incidents could harm the business and reputation.
• Economic slowdowns or factors affecting the U.S., India, or the IT, healthcare, and streaming industries may adversely affect the business.
• Liability issues are inherent in the healthcare industry, and insurance is expensive and difficult to obtain.
• Failure to develop and maintain effective internal control over financial reporting and disclosure controls could lead to inaccurate financial reporting.
• Reliance on information technology means failure to adapt to technological developments could harm the business.
• Reliance on third-party systems and service providers means disruptions could have a material adverse effect.
• Potential intellectual property infringement claims may be expensive to defend and disrupt operations.
• Software errors or defects in platforms and internal systems could adversely affect the business.
• Dependence on maintaining relationships with business partners and other third parties.
• No plans to pay dividends in the foreseeable future.
• Substantial business and operations in India subject the company to regulatory, economic, social, and political uncertainties.
• Restrictions on foreign investment in India may prevent future acquisitions or investments.
• The business is regulated by The Competition Act, 2002, in India, with unclear effects.
• The healthcare industry in India is subject to extensive laws and regulations, with potential for increased costs and operational impediments.
• Infrastructure in India may not be upgraded to support higher internet penetration, requiring additional investments.
• Inability to obtain additional financing on acceptable terms could prevent business development.
• Operating in highly competitive industries with larger, more capitalized competitors.
• Success in healthcare depends on recruiting and retaining experienced therapists.
• Healthcare provider licensing and credentialing costs can negatively impact margins, especially when expanding to new jurisdictions.
• The telehealth market is immature and volatile; slow development or negative publicity could harm business growth.
• Legal challenges to the business model or actions restricting service provision in certain jurisdictions could adversely affect operations.
• Need to increase organization size and manage growth effectively.
• Failure to maintain or enhance consumer awareness of the brand could have a material adverse effect.
• Inability to successfully implement growth strategies or pursue strategic partnerships and acquisitions.
• Failure to identify and exploit new market opportunities could lead to declining future revenues.
• Difficult market conditions, economic conditions, and geopolitical uncertainties could adversely affect business and profitability.
• Changing laws, rules, and regulations, including adverse tax law applications, may affect business and financial performance.
• Results of operations are subject to fluctuations in currency exchange rates.

Future Outlook

The company plans to launch subscription-based remote patient monitoring devices in India in the second half of 2025 and deploy similar devices in the United States. The rollout of local health centers and diagnostic centers in India is expected to commence in the second half of 2025 and take 24 months to complete. Fintech services are initially planned for Sri Sai customers, focusing on converting cash collections to e-wallet payments, with future plans for credit cards and microloans. Lytus Studios intends to produce original content for the Lytus Play streaming platform. Management believes the offering proceeds will cover cash needs for the next 12 months.

Management Comments

• Management believes that the decrease in subscribers is marginal and will be retained when platform services are launched.
• Management believes that the proceeds from this offering will be sufficient to satisfy the Company's cash needs for the next 12 months.

Industry Context

StockSavvy.ai notes that Lytus Technologies is positioning itself to capitalize on India's e-commerce boom and the evolving telemedicine regulatory landscape. The company's strategy to upgrade existing cable networks to Fiber to the Home (FTTH) and Gigabit Passive Optical Networks (GPON) aligns with the increasing demand for broadband and IPTV services in India, driven by rapid urbanization and digital transformation initiatives. The expansion into healthtech and fintech places Lytus in highly competitive sectors with established players like JioHotstar, Netflix, Practo, 1mg, Amazon Pay, and Ola Money, requiring significant innovation and market penetration efforts to secure substantial share.

Comparison to Industry Standards

• The filing lists several competitors in streaming (JioHotstar, Netflix, Olly Plus), telemedicine (Practo, 1mg, Apollo 24/7), and fintech (Amazon Pay, Ola Money, JioMoney). However, it does not provide specific financial or operational benchmarks for direct comparison against these industry leaders.
• Lytus's reported 4 million active users, derived from 1 million paid home subscribers, is a significant base within the Indian market, but direct comparison to the active user counts of competitors like JioHotstar (approx. 300 million active users) highlights the scale difference.
• The company's focus on upgrading existing cable networks to FTTH/GPON and developing proprietary healthtech and fintech platforms indicates an effort to modernize and diversify, which is a common strategy among traditional service providers facing disruption from OTT and digital services.

Corporate Governance

Legal Proceedings

• A complaint was filed on May 22, 2020, against CEO Dharmesh Pandya by Securitax Ltd. and Optimal US Logistics, LLC, alleging breach of contract and fiduciary duty, claiming $854,000 in damages. The company believes these claims are false and frivolous, and Mr. Pandya is actively defending them, with mediation ongoing.

Related Party Transactions

• Subscription income from related parties: $518,795 (FY2025) and $107,322 (FY2024).
• STB Installation charges from related parties: $48,445 (FY2025) and $61,628 (FY2024).
• Loans taken from KMP: $272,365 (FY2025) and $1,850,313 (FY2024).
• Loans taken from relatives of KMP: $124,918 (FY2024).
• Loan repayment to KMP: $1,543,653 (FY2025) and $912,506 (FY2024).
• Loan repayment to relatives of KMP: $19,012 (FY2025) and $93,704 (FY2024).
• Commission expenses to significant influence entities: $1,305,186 (FY2025) and $1,047,025 (FY2024).
• Bandwidth charges to significant influence entities: $24,339 (FY2025) and $24,098 (FY2024).
• Sales/Purchase of materials with significant influence entities: $8,602 (FY2025) and $1,297 (FY2024).
• Fiber Maintenance Expense with significant influence entities: $1,502 (FY2025).
• Consultancy Services (Revenue) with significant influence entities: $1,061,622 (FY2025).
• IT support Charges with significant influence entities: $5,908 (FY2025).
• Remuneration to KMP: $141,797 (FY2025) and $285,294 (FY2024).
• Remuneration to relatives of KMP: $38,286 (FY2025) and $36,103 (FY2024).
• Rent paid/provided to KMP: $7,802 (FY2025) and $7,459 (FY2024).
• Interest on loan to KMP: $212 (FY2025) and $218 (FY2024).
• Investment in CCD of Subsidiary: $3,817,490 (FY2025) and $135,000 (FY2024).
• Reimbursement of expenses to KMP: $92,246 (FY2025) and $29,266 (FY2024).
• Loans and Advances given to significant influence entities: $239,684 (FY2025) and $18,173 (FY2024).
• Loans and Advances given to relatives of KMP: $97,355 (FY2024).
• Loans and Advances received back from KMP: $214,458 (FY2025).
• Advances for network acquisition with significant influence entities: $16,661 (FY2025).
• Outstanding loan payable to KMP: $164,124 (FY2025) and $1,458,845 (FY2024).
• Outstanding loan payable to relatives of KMP: $31,019 (FY2024).
• Outstanding loan receivable from significant influence entities: $35,598 (FY2025) and $95,443 (FY2024).
• Outstanding receivable from KMP: $214,458 (FY2025) and $1,354,871 (FY2024).
• Outstanding receivable from significant influence entities: $1,083,034 (FY2024).
• IPO amount with Lytus Inc Receivable: $118,728 (FY2025) and $118,728 (FY2024).
• IPO amount of Lytus BVI Payable: $20,507 (FY2024).

Stakeholder Impact

• Shareholders: Will experience immediate and substantial dilution of approximately $0.36 per share for new investors. Existing shareholders will see a decrease of $0.25 per share in net tangible book value. The Nasdaq listing, if approved, could increase liquidity and visibility, but the investment remains highly speculative.
• Employees: The 2023 Employee Incentive Plan is in place, with shares issued to the Lytus Trust for future allocation, aiming to attract, retain, and motivate staff. However, deferred compensation for CEO and CFO for FY2024 and FY2025 remains unpaid.
• Customers: The company's strategy to upgrade cable networks and expand into healthtech and fintech aims to offer enhanced and multi-dimensional services, potentially improving customer experience and loyalty.
• Creditors: A portion of the offering proceeds ($1.6 million) will be used to repay outstanding indebtedness to Yorkville, improving the company's debt profile.
• Underwriters: American Trust Investment Services, Inc. and WestPark Capital, Inc. will receive underwriting discounts, commissions, and a non-accountable expense allowance, along with warrants, for their role in the offering.

Next Steps

• Obtain approval for listing common shares on the Nasdaq Capital Market.
• Consummate the public offering of common shares.
• Continue beta testing and launch remote patient monitoring devices in India in the second half of 2025.
• Commence rollout of local health centers and diagnostic centers in India in the second half of 2025, with a 24-month completion timeline.
• Deploy remote patient monitoring devices in the United States via Lytus Health in the second half of 2025.
• Fund Lytus Studios to produce original content for the Lytus Play streaming platform.
• Expand Fintech services to Sri Sai customers, focusing on e-wallet payments, credit cards, and microloans.
• Remediate identified material weaknesses in internal control over financial reporting and improve disclosure controls and procedures.

Key Dates

Recommendation

The company is in a transitional phase, seeking to uplist to Nasdaq and expand its business verticals. While revenue growth is positive, the significant decline in net income and identified material weaknesses in internal controls present considerable risks. The success of the public offering and Nasdaq listing is crucial for future growth and liquidity. Given the high degree of speculative risk and the mixed financial performance, a 'hold' recommendation is appropriate for existing investors, while new investors should exercise extreme caution due to the inherent uncertainties and potential for further dilution.

Keywords

Streaming Services, Telemedicine, Fintech, India Market, Nasdaq Uplisting, Public Offering, SEC F-1/A, Cable Networks, Digital Platforms, Subscriber Growth, Healthtech, Financial Technology, Emerging Growth Company, Foreign Private Issuer, Controlled Company, British Virgin Islands, Corporate Governance, Risk Factors, Financial Reporting, Capital Raise, Reverse Stock Split